Page last updated: 2024-11-02

pifithrin and Kidney Diseases

pifithrin has been researched along with Kidney Diseases in 2 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research Excerpts

ExcerptRelevanceReference
"Renal ischemia reperfusion injury is known to shorten telomeres and upregulate stress-induced genes, such as the cyclin-dependent kinase (CDK) inhibitor p21."1.34p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury. ( Heininger, D; Hochegger, K; Huber, JM; Koppelstaetter, C; Mayer, G; Rosenkranz, AR; Tagwerker, A, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sprowl, JA1
Lancaster, CS1
Pabla, N1
Hermann, E1
Kosloske, AM1
Gibson, AA1
Li, L1
Zeeh, D1
Schlatter, E1
Janke, LJ1
Ciarimboli, G1
Sparreboom, A1
Hochegger, K1
Koppelstaetter, C1
Tagwerker, A1
Huber, JM1
Heininger, D1
Mayer, G1
Rosenkranz, AR1

Other Studies

2 other studies available for pifithrin and Kidney Diseases

ArticleYear
Cisplatin-induced renal injury is independently mediated by OCT2 and p53.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Aug-01, Volume: 20, Issue:15

    Topics: Animals; Antineoplastic Agents; Benzothiazoles; Biomarkers; Cisplatin; Female; Gene Expression Profi

2014
p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury.
    American journal of physiology. Renal physiology, 2007, Volume: 292, Issue:2

    Topics: Animals; Benzothiazoles; Biomarkers; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase

2007